Literature DB >> 16724486

Adaptive design in clinical research: issues, opportunities, and recommendations.

Mark Chang1, Shein-Chung Chow, Annpey Pong.   

Abstract

The issues and opportunities of adaptive designs are discussed. Starting with the definitions of an adaptive design, its validity and integrity are discussed. The three key components of an adaptive design, i.e., Type I error control, p-value adjustment, and unbiased estimation and confidence interval are addressed. Various seamless designs are investigated. Recommendations are made in the following aspects: study planning, trial monitoring, analysis and reporting, trial simulation, and regulatory perspectives.

Mesh:

Year:  2006        PMID: 16724486     DOI: 10.1080/10543400600609718

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  12 in total

1.  Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.

Authors:  Roland B Walter; Frederick R Appelbaum; Martin S Tallman; Noel S Weiss; Richard A Larson; Elihu H Estey
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  BMJ       Date:  2020-06-17

Review 3.  Controversies in Alzheimer's disease drug development.

Authors:  Jeffrey L Cummings
Journal:  Int Rev Psychiatry       Date:  2008-08

4.  An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials.

Authors:  Michael Y Mi; Rebecca A Betensky
Journal:  Clin Trials       Date:  2013-01-02       Impact factor: 2.486

5.  The utility of Google Trends data to examine interest in cancer screening.

Authors:  M Schootman; A Toor; P Cavazos-Rehg; D B Jeffe; A McQueen; J Eberth; N O Davidson
Journal:  BMJ Open       Date:  2015-06-08       Impact factor: 2.692

6.  Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approaches.

Authors:  David M Marks; Thanaseelan J; Chi-Un Pae
Journal:  Psychiatry Investig       Date:  2009-03-31       Impact factor: 2.505

7.  The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  Trials       Date:  2020-06-17       Impact factor: 2.279

8.  Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials.

Authors:  Munyaradzi Dimairo; Jonathan Boote; Steven A Julious; Jonathan P Nicholl; Susan Todd
Journal:  Trials       Date:  2015-09-28       Impact factor: 2.279

9.  Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials.

Authors:  Munyaradzi Dimairo; Steven A Julious; Susan Todd; Jonathan P Nicholl; Jonathan Boote
Journal:  Trials       Date:  2015-12-23       Impact factor: 2.279

Review 10.  Emerging technologies to measure neighborhood conditions in public health: implications for interventions and next steps.

Authors:  M Schootman; E J Nelson; K Werner; E Shacham; M Elliott; K Ratnapradipa; M Lian; A McVay
Journal:  Int J Health Geogr       Date:  2016-06-23       Impact factor: 3.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.